NEW YORK (GenomeWeb News) – Molecular diagnostics laboratory Exagen Diagnostics today announced it has received accreditation from the College of American Pathologists.
As a result, Exagen becomes one of more than 17,000 CAP-accredited labs around the world. Based in Albuquerque, N.M., Exagen develops and markets genomic tests.
"As we continue to develop new genomic tests independently and through partnerships with pharmaceutical and diagnostics companies, having CAP accreditation validates our position as one of the world's most forward-looking laboratories," said Exagen Clinical Laboratory Director John Hozier, said in a statement.
CAP accreditation is based on an on-site inspection of the laboratory's records and quality-control procedures for the preceding two years, laboratory staff qualifications, and laboratory equipment, among other things.